Myostatin inhibitors and the paradox of larger but weaker muscles
Preview text: Drugs, new and old, that preserve lean mass, but fail to boost strength

Use this example
- Subject
- Myostatin inhibitors and the paradox of larger but weaker muscles
- Preview text
- Drugs, new and old, that preserve lean mass, but fail to boost strength
- From
- peter@
peterattiamd.com - Brand
- Peter Attia, M.D.
- ESP
- Klaviyo
- Sent
- Sun Oct 4, 2026, 7:00 AM ET
- Sent to
- peterattiamd.com
- Size
- 43 KB
- Images
- 6
- Links
- 7, 4 of them buttons
- Subject length
- 66 characters
Against Peter Attia, M.D.'s usual
Sent in its busiest hour, 7 AM, which holds 100% of its emails. The subject is 66 characters, the same as its average.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Peter Attia, M.D. <[email protected]>
- Subject
- Myostatin inhibitors and the paradox of larger but weaker muscles
- Date
- Sun, 04 Oct 2026 11:00:54 +0000
- Message-ID domain
- klaviyomail.com
- Return-Path domain
- k3.send.peterattiamd.com
- DKIM signature
- d=shared.klaviyomail.com s=def1; d=send.peterattiamd.com s=mtd1
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from (unnamed) by kmta-mta-blue-….servers.clovesoftware.com with SMTP
Other sending headers (names only): X-Mailer-Info-Extra2, X-Mailer-Info, X-Mailer-Info-Extra, X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse
Sent just before and after
| Oct 12, 2026 7:02 AM | Strong convictions, loosely held: how Peter’s views on fasting, keto, metformin, rapamycin, whole-body MRI, and exercise have changed | |
| Oct 11, 2026 7:02 AM | How much do symptomatic treatments for Alzheimer’s disease help? | |
| Oct 5, 2026 7:02 AM | The biology of pregnancy: physiologic adaptation, gestational diabetes, preeclampsia, childbirth, and long-term maternal health | |
| Oct 4, 2026 7:00 AM | Myostatin inhibitors and the paradox of larger but weaker muscles (this email) | |
| Sep 30, 2026 7:03 AM | The end of Alzheimer’s? | |
| Sep 28, 2026 7:01 AM | Inside modern drug development: the science, economics, and regulatory hurdles behind bringing new medicines to patients | |
| Sep 27, 2026 7:02 AM | Prioritizing health interventions |
More from Peter Attia, M.D.
All Peter Attia, M.D. emailsNov 9, 2026 7:02 AM
Nov 8, 2026 7:01 AM
Nov 2, 2026 7:02 AM
Who is actually at risk for CTE?
Nov 1, 2026 7:00 AM
A longevity playbook for building strength and muscle mass
Oct 29, 2026 7:00 AM
Oct 26, 2026 7:01 AM
Personalized medicine comes to cancer immunotherapy
Oct 25, 2026 7:03 AM
Oct 19, 2026 7:01 AM







